ID ASPD_METHJ Reviewed; 252 AA. AC Q2FSK9; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 21-MAR-2006, sequence version 1. DT 16-JUN-2009, entry version 24. DE RecName: Full=Probable L-aspartate dehydrogenase; DE EC=1.4.1.21; GN Name=nadX; OrderedLocusNames=Mhun_2354; OS Methanospirillum hungatei (strain JF-1 / DSM 864). OC Archaea; Euryarchaeota; Methanomicrobia; Methanomicrobiales; OC Methanospirillaceae; Methanospirillum. OX NCBI_TaxID=323259; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C., Glavina T., RA Hammon N., Israni S., Pitluck S., Brettin T., Bruce D., Han C., RA Tapia R., Gilna P., Kiss H., Schmutz J., Larimer F., Land M., RA Kyrpides N., Ivanova N., McInerney M.J., Brockman F., Culley D., RA Ferry J.G., Gunsalus R.P., Morrison M., Plugge C., Scholten J., RA Stams A.J.M., Boone D.R., Richardson P.; RT "Complete sequence of Methanospirillum hungatei JF-1."; RL Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Specifically catalyzes the NAD or NADP-dependent CC dehydrogenation of L-aspartate to iminoaspartate (By similarity). CC -!- CATALYTIC ACTIVITY: L-aspartate + H(2)O + NAD(P)(+) = oxaloacetate CC + NH(3) + NAD(P)H. CC -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; CC iminoaspartate from L-aspartate (dehydrogenase route): step 1/1. CC -!- MISCELLANEOUS: The iminoaspartate product is unstable in aqueous CC solution and can decompose to oxaloacetate and ammonia (By CC similarity). CC -!- SIMILARITY: Belongs to the L-aspartate dehydrogenase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CP000254; ABD42058.1; -; Genomic_DNA. DR RefSeq; YP_503777.1; -. DR GeneID; 3923251; -. DR GenomeReviews; CP000254_GR; Mhun_2354. DR KEGG; mhu:Mhun_2354; -. DR NMPDR; fig|323259.5.peg.2478; -. DR HOGENOM; Q2FSK9; -. DR OMA; Q2FSK9; ECAGHSA. DR BioCyc; MHUN323259:MHUN_2354-MON; -. DR GO; GO:0033735; F:aspartate dehydrogenase activity; IEA:EC. DR GO; GO:0051287; F:NAD or NADH binding; IEA:HAMAP. DR GO; GO:0050661; F:NADP or NADPH binding; IEA:HAMAP. DR GO; GO:0016639; F:oxidoreductase activity, acting on the CH-N...; IEA:HAMAP. DR GO; GO:0009435; P:NAD biosynthetic process; IEA:HAMAP. DR GO; GO:0006742; P:NADP catabolic process; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR HAMAP; MF_01265; -; 1. DR InterPro; IPR005106; Asp/hSer_DH_NAD-bd. DR InterPro; IPR002811; Asp_DH. DR InterPro; IPR011182; Asp_DH_NAD_syn. DR InterPro; IPR016040; NAD(P)-bd_dom. DR Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1. DR Pfam; PF01958; DUF108; 1. DR Pfam; PF03447; NAD_binding_3; 1. DR PIRSF; PIRSF005227; Asp_dh_NAD_syn; 1. DR ProDom; PD017325; Asp_dh; 1. PE 3: Inferred from homology; KW Complete proteome; NAD; NADP; Oxidoreductase; KW Pyridine nucleotide biosynthesis. FT CHAIN 1 252 Probable L-aspartate dehydrogenase. FT /FTId=PRO_1000067305. FT ACT_SITE 203 203 By similarity. FT BINDING 119 119 NAD; via amide nitrogen (By similarity). FT BINDING 175 175 NAD (By similarity). SQ SEQUENCE 252 AA; 27227 MW; DB0A2E0F122E4710 CRC64; MVRIGLLGCG NVGRIIATHQ DGFTVEALFD RLPDHAEELA RMCGAPAYAD FQEFISQDFD ICVEAASVLA VREYAPKILE NGKHVLILSV GALSDTNFRK ILLDVARSQG KKIHIPSGAI MGLDNLKVGG ISRIDSVLLR TTKSPASLGM QVSHRTLAFR GKANECIKQF PKNINVSVAL ALAVHHDVDV ELWADPEVDR NIHDIFVSGE FGEASIRVVN HPSPDNPATS YLAALSVLSL LKNLDSPLVI GS //